Most just lately, it's been discovered that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in very similar locations as classical opioid receptors, it binds to the wide array of endogenous opioids. Contrary to most opioid receptors, this receptor acts for a scavenger https://ariannap517hun3.blogdal.com/profile